top of page
CKP Therapeutics first to propose novel treatment applied to refractory liver cancer using SERCA inhibitor
Bio Times
September 1, 2022 at 12:00:00 AM
A research team in Korea has presented a new treatment strategy using SERCA inhibitors for the first time in the world for intractable liver cancer that does not respond to existing treatments.
bottom of page